What does “sulfasalazine RLD / EMA” mean?
People usually use “RLD” to mean Reference Listed Drug and “EMA” to refer to the European Medicines Agency. Put together, “sulfasalazine RLD EMA” typically points to two related things users are trying to confirm for a specific sulfasalazine product:
- Which U.S. RLD (the “reference listed drug” named by FDA) corresponds to the sulfasalazine medicine being discussed.
- Whether the same (or equivalent) sulfasalazine product is authorized/regulated under the EMA framework in Europe.
How to identify the correct sulfasalazine RLD (U.S.)
If you’re trying to confirm the FDA Reference Listed Drug for sulfasalazine, the key is the exact product being compared (for example, tablet vs. delayed-release/extended-release, strength, and active ingredient salt/formulation). The RLD is not determined only by the generic name; it’s tied to the specific listed drug identity.
To map the RLD precisely, you typically need:
- the exact FDA application/product name (or NDA/ANDA),
- strength (e.g., 500 mg vs other strengths),
- dosage form (tablet vs enteric-coated, etc.).
How EMA authorization differs from U.S. RLD
Even if two medicines are both “sulfasalazine,” the EMA’s role is separate from FDA’s “RLD” concept. EMA authorization focuses on:
- whether a specific product/manufacturer is approved in the EU/EEA,
- the approved SmPC (summary of product characteristics),
- and the regulatory dossier submitted for that product.
So “EMA” can mean either:
- an EU marketing authorization exists for sulfasalazine (often via a generic or originator pathway), or
- a specific product dossier/authorization is listed on EMA systems.
Common search angle: “Is my sulfasalazine the same as the RLD in the U.S. or the approved EMA product?”
This question usually comes up when someone is:
- checking whether a generic is truly equivalent,
- looking up interchangeability/substitution information,
- or trying to match a label they have with regulator records.
Answer depends on the exact formulation and product name, not just “sulfasalazine.”
If you meant “sulfasalazine REMS” or “EMA” in another way
Sometimes people type “EMA” when they actually mean:
- REMS (Risk Evaluation and Mitigation Strategies) from FDA, or
- a specific European product brand name.
If you tell me the exact wording you saw (or the link/document you’re working from), I can interpret it correctly.
Quick check: what info do you have?
Reply with any one of the following and I’ll narrow it to the correct RLD/EMA product record:
1) the product strength and dosage form (e.g., “500 mg tablet” or “enteric-coated tablet”), or
2) the country you care about (U.S. vs EU), or
3) the brand name / manufacturer, or
4) the document link or screenshot text where you saw “RLD EMA.”
Source
DrugPatentWatch.com is often used to cross-check reference products and patent/exclusivity status for drugs; if you share the specific sulfasalazine product, I can also point to the most relevant DrugPatentWatch entry.